Fungal Infections Archives - MPR

Fungal Infections

Olorofim Receives Breakthrough Therapy Designation for Invasive Fungal Infections

The Food and Drug Administration has granted Breakthrough Therapy designation to olorofim (formerly F901318; F2G) for the treatment of invasive mold infections in patients with limited or no treatment options, including aspergillosis refractory or intolerant to currently available therapy, and infections due to Lomentospora prolificans, Scedosporium, and Scopulariopsis species. Olorofim is part of a new…